Filing Details

Accession Number:
0001209191-21-026247
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-09 16:36:31
Reporting Period:
2021-04-08
Accepted Time:
2021-04-09 16:36:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1761612 Bicycle Therapeutics Plc BCYC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1391045 Pierre Legault C/O Bicycle Therapeutics Plc
B900, Babraham Research Campus
Cambridge X0 CB22 3AT
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-04-08 24,838 $8.74 24,838 No 4 M Direct
Ordinary Shares Disposition 2021-04-08 12,500 $32.00 12,338 No 4 S Direct
Ordinary Shares Disposition 2021-04-08 12,099 $31.40 239 No 4 S Direct
Ordinary Shares Disposition 2021-04-08 239 $32.13 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2021-04-08 24,838 $0.00 24,838 $8.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
173,312 2029-04-25 No 4 M Direct
Footnotes
  1. This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.37265 to GBP 1.00 as of April 8, 2021.
  2. Shares were sold pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to$31.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4).
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.16 inclusive.
  5. This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.